Search Within

Gary Ulaner

Formats
  1. Journal Article (95)
  2. Meeting Abstract (39)
  3. Miscellaneous (5)
  4. Review (4)
  5. Editorial (2)
  6. Book Whole (1)
  7. Guidelines (1)
Groups
  1. Molecular Imaging and Therapy Service (147)
  2. Radiology, Department of (147)
  3. Department of Medicine (75)
  4. Solid Tumor Oncology Division (60)
  5. GSK Faculty (59)
  6. Epidemiology and Biostatistics (46)

More Groups

People
  1. David Hyman (22)
  2. Christopher Riedl (21)
  3. Maxine Jochelson (21)
  4. Jason Lewis (20)
  5. Maura Dickler (19)
  6. Komal Jhaveri (18)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Journal of Nuclear Medicine (24)
  2. Clinical Nuclear Medicine (23)
  3. Journal of Clinical Oncology (16)
  4. Cancer Research (8)
  5. PET Clinics (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (27)
  2. Society of Nuclear Medicine (24)
  3. American Society of Clinical Oncology (16)
  4. Elsevier Inc. (16)
  5. American Association for Cancer Research (12)
  6. Springer (8)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Mcarthur, H. L.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Reply: Breast cancer staging: To which women should 18F-FDG PET/CT be offered?
    Journal Article

    Ulaner, G. A.; Riedl, C. C.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Phase I, open-label study evaluating the safety and tolerability of LJM716, BYL719 and trastuzumab in patients with metastatic HER2+ breast cancer
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Ulaner, G.; Zamora, S.; Sterlin, V.; Iasonos, A.; Dickler, M. N.; Moynahan, M. E.; Hudis, C. A.; Baselga, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I study of ARN-810, a novel and potent oral selective estrogen receptor degrader, in postmenopausal women with metastatic estrogen receptor positive (ER+), HER2-breast cancer
    Meeting Abstract

    Bardia, A.; Dickler, M. N.; Mayer, I. A.; Winer, E. P.; Mahmood, U.; Ulaner, G.; Manning, H. C.; Rix, P.; Hager, J. H.; Roychowdhury, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Meikle, J.; Schoder, H.; Ulaner, G. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Comparison of MRI perfusion and PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation
    Meeting Abstract

    Yang, T.; Young, R.; Hatzoglou, V.; Ulaner, G.; Schneider, T.; Omuro, A.; Chan, T.; Yamada, Y.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years
    Journal Article

    Riedl, C. C.; Slobod, E.; Jochelson, M.; Morrow, M.; Goldman, D. A.; Gonen, M.; Weber, W. A.; Ulaner, G. A.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • FDG PET/CT findings in a rare case of giant fibrovascular polyp of the esophagus harboring atypical lipomatous tumor/well-differentiated liposarcoma
    Journal Article

    Beylergil, V.; Simmons, M. Z.; Ulaner, G.; Jurcic, J.; Hibshoosh, H.; Carrasquillo, J. A.
    Clinical Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if18F-FDG PET/CT is performed?
    Journal Article

    Ulaner, G. A.; Magnan, H.; Healey, J. H.; Weber, W. A.; Meyers, P. A.
    American Journal of Roentgenology (2014)

    Fulltext@MSK | Save